Forecast: (IONS) for 2024-2028
Ionis Pharmaceuticals Inc icon

Forecast: (IONS) for 2024-2028

Updated: January 18, 2024

An Insight into Ionis Pharmaceuticals Inc

Ticker: IONS

Sector: Life sciences

Closing price of the last trading day: $

Last trading day: 01/01/1970

Analyst forecast price: $54.62

52-week high/low: $54.44 / $32.69

On the global stage, Ionis Pharmaceuticals Inc commands attention, with its shares actively traded under the ticker IONS. A notable entity in the "Life sciences" sector, it showcases a blend of innovation and market resilience. Nestled at 2855 GAZELLE COURT, CARLSBAD, CA, US, the head office stands as a nexus where strategic decisions and innovations emanate. It boasts a market capitalization of $7 251 792 000, reflecting its substantial footprint in the industry. With 143 472 000 shares oscillating in the vibrant market, every transaction echoes the company’s undeterred progression. A glimpse into the last fiscal year reveals EBITDA standing at -540 307 008$. It indicates a phase of economic recalibration, a precursor to potential upswings.

Engaging in a deeper analytical discourse, investors and market watchers alike often turn to resources like Allforecast.com. Here, comprehensive insights, data analytics, and predictive metrics about companies like Ionis Pharmaceuticals Inc are made available. This rich reservoir of information aids in informed decision-making, blending historical data with future predictions to paint a holistic picture of stock performance trajectories.



Unraveling Ionis Pharmaceuticals Inc (IONS) Stock Predictions for 2025

In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Ionis Pharmaceuticals Inc and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Our consensus forecast for 2025 is a composite reflection of diverse expert analyses, ensuring a balanced and informed perspective for potential investors and market enthusiasts.

We encapsulate our insights visually, offering a detailed forecast chart for Ionis Pharmaceuticals Inc in 2025. This visual representation is a blend of historical and projected data, offering a comprehensive view of the stock’s performance. The grey trajectory delineates the historical performance of IONS, while the turquoise trajectory illuminates the anticipated performance, encapsulating potential fluctuations and trends.

At Allforecast.com, we go beyond conventional data presentation. Our analyses are ingrained with depth, offering not just numbers but insights that empower informed decision-making. For Ionis Pharmaceuticals Inc, each data point, each trend, and each projection is a story of potential opportunities, risks, and strategic decisions. Navigate through the intricate world of stocks with data that is as comprehensive as it is precise.

Analyzing the anticipated performance of Ionis Pharmaceuticals Inc, the ceiling value that the stock is expected to reach in 2025 stands at a promising $61.84. Indicating a bullish trend, an upside potential of 20.57% signals profitable prospects, with an average monthly return of 0.89%, beckoning investors to consider amplifying their portfolios.

On the flip side, the floor value that Ionis Pharmaceuticals Inc stock may plummet to in 2025 is $42.34. Highlighting a potential decline of 21.15%, cautious investment and vigilant monitoring become paramount.

In the grand scheme, a price oscillation channel for Ionis Pharmaceuticals Inc is foreseeable, bounded by a resistance level of $61.84 and a support frontier at $42.34. This fluctuation breadth of $19.5 presents nuanced investment gateways and exit junctures, pivotal for strategic stock trading.

The pendulum of market dynamics sways amidst myriad factors. The juxtaposition of historical trends, current market sentiments, and forward-looking analytics offers a comprehensive panorama. The breakout potential, trajectory sustenance, and market volatilities are intrinsically tied to economic indicators, policy shifts, and industry innovations. For Ionis Pharmaceuticals Inc, every forecast, every percentage point, and every market prediction is not just a statistical data point but a narrative woven into the fabric of its corporate journey. As investors and market watchers alike toggle between optimism and caution, each prediction, each high and low, charts the course of Ionis Pharmaceuticals Inc in the bustling marketplace.

Ascend or descend, each move of Ionis Pharmaceuticals Inc stock is a pulse in the financial markets, echoing the rhythms of economic cycles, investor sentiments, and market dynamics. With the dawn of each trading day, new opportunities and challenges emerge, painting a vibrant tapestry of Ionis Pharmaceuticals Inc's stock trajectory in the canvas of global finance.

Let’s delve into an analytical exploration of the support level's robustness for Ionis Pharmaceuticals Inc stocks. The stock is projected to hover around the support level for 1 month, reflecting the temporal dynamics of Ionis Pharmaceuticals Inc's stock price. The resilience of the existing support level underscores its reliability, minimizing the likelihood of a downtrend.

Furthermore, it's pivotal to consider that the actual future valuation of Ionis Pharmaceuticals Inc shares is susceptible to market volatilities and can oscillate both above and below the anticipated forecast price. Yet, it is generally anticipated to oscillate within the confines of the pessimistic and optimistic target price projections. This nuance is integral for investors aiming for balanced portfolio diversification and risk mitigation.

Each projection and statistical insight into Ionis Pharmaceuticals Inc's performance not only informs investment strategies but also adds a layer to the unfolding narrative of its market journey. As numbers dance and trends oscillate, every investor, analyst, and market enthusiast becomes a witness to the dynamic ballet of figures, forecasts, and financial crescendos that define the stock’s story.

With the interplay of data, predictions, and real-time performance, Ionis Pharmaceuticals Inc's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.
Table of forecasts for 2025.
Month Mid Low High Range, %
January 2025 44.54 43.56 46.41 6.14 %
February 2025 48.06 44.93 51.66 13.02 %
March 2025 52.33 49.14 54.27 9.45 %
April 2025 52.91 50.10 56.72 11.66 %
May 2025 54.97 51.73 58.98 12.30 %
June 2025 53.43 50.07 55.94 10.51 %
July 2025 57.17 55.17 61.75 10.65 %
August 2025 57.69 53.19 61.84 13.99 %
September 2025 52.15 51.00 55.23 7.65 %
October 2025 51.00 48.25 52.07 7.35 %
November 2025 50.44 47.97 52.66 8.91 %
December 2025 47.31 45.75 49.92 8.34 %

Forecast for January 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $43.56 to $46.41. The width of this range will be $2.85 (6.14%). The average price is $44.54, which is $1.66 less than the average price of the previous month.

Forecast for February 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $44.93 to $51.66. The width of this range will be $6.73 (13.02%). The average price is $48.06, which is $3.52 higher than the average price of the previous month.

Forecast for March 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $49.14 to $54.27. The width of this range will be $5.13 (9.45%). The average price is $52.33, which is $4.28 higher than the average price of the previous month.

Forecast for April 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $50.10 to $56.72. The width of this range will be $6.61 (11.66%). The average price is $52.91, which is $0.58 higher than the average price of the previous month.

Forecast for May 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $51.73 to $58.98. The width of this range will be $7.26 (12.30%). The average price is $54.97, which is $2.06 higher than the average price of the previous month.

Forecast for June 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $50.07 to $55.94. The width of this range will be $5.88 (10.51%). The average price is $53.43, which is $1.54 less than the average price of the previous month.

Forecast for July 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $55.17 to $61.75. The width of this range will be $6.57 (10.65%). The average price is $57.17, which is $3.74 higher than the average price of the previous month.

Forecast for August 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $53.19 to $61.84. The width of this range will be $8.65 (13.99%). The average price is $57.69, which is $0.51 higher than the average price of the previous month.

Forecast for September 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $51.00 to $55.23. The width of this range will be $4.22 (7.65%). The average price is $52.15, which is $5.54 less than the average price of the previous month.

Forecast for October 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $48.25 to $52.07. The width of this range will be $3.83 (7.35%). The average price is $51.00, which is $1.15 less than the average price of the previous month.

Forecast for November 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $47.97 to $52.66. The width of this range will be $4.69 (8.91%). The average price is $50.44, which is $0.56 less than the average price of the previous month.

Forecast for December 2025.

It is predicted that the price of one Ionis Pharmaceuticals Inc share in will be in the range of $45.75 to $49.92. The width of this range will be $4.16 (8.34%). The average price is $47.31, which is $3.13 less than the average price of the previous month.

Read more


Denial of responsibility:

All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them to a single whole. The portal allforecast.com is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.